Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 02 Jul 2027. This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent warrants further development. In addition to preclinical efficacy, accompanying pharmacodynamic and pharmacokinetic…
Opportunity overview
- Project name
- Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
- Donor
- National Institutes of Health
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
Summary
Frequently asked questions
What is Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)?
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 02 Jul 2027. This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent warrants further development. In addition to preclinical efficacy, accompanying pharmacodynamic and pharmacokinetic…
Who is funding Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)?
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) is funded by National Institutes of Health.
When is the deadline to apply for Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)?
The application deadline is 02 Jul 2027 00:00 (UTC).
Where will the Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) project take place?
The project location(s) are: United States.
How can I apply for Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.